Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions

• Published in: Methods and protocols Vol. 5; no. 5; p. 78
• Main Authors: Gallivanone, Francesca, Bertoli, Gloria, Porro, Danilo
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 03.10.2022; MDPI
• Subjects: Biomarkers; Biopsy; Breast cancer; Diagnosis; Gene expression; Image processing; imaging; Mammography; Medical prognosis; Metastasis; MicroRNAs; MRI; Mutation; Patients; PET/CT; Precision medicine; Proteins; Proteomics; radiogenomic; Radiomics; Review; Transcriptomics; Womens health
• ISSN: 2409-9279; 2409-9279
• DOI: 10.3390/mps5050078

Breast cancer (BC) is a heterogeneous disease, affecting millions of women every year. Early diagnosis is crucial to increasing survival. The clinical workup of BC diagnosis involves diagnostic imaging and bioptic characterization. In recent years, technical advances in image processing allowed for the application of advanced image analysis (radiomics) to clinical data. Furthermore, -omics technologies showed their potential in the characterization of BC. Combining information provided by radiomics with –omics data can be important to personalize diagnostic and therapeutic work up in a clinical context for the benefit of the patient. In this review, we analyzed the recent literature, highlighting innovative approaches to combine imaging and biochemical/biological data, with the aim of identifying recent advances in radiogenomics applied to BC. The results of radiogenomic studies are encouraging approaches in a clinical setting. Despite this, as radiogenomics is an emerging area, the optimal approach has to face technical limitations and needs to be applied to large cohorts including all the expression profiles currently available for BC subtypes (e.g., besides markers from transcriptomics, proteomics and miRNomics, also other non-coding RNA profiles).